Health & Fitness
Health and Fitness
Health and Fitness
Tue, February 17, 2009 Inspire Announces Date for Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results
DURHAM, N.C.--([ BUSINESS WIRE ])--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that it plans to report fourth quarter and full year 2008 financial results on Tuesday, March 3, 2009 before the market opens. Inspire's President and CEO, Christy L. Shaffer, Ph.D., and Executive Vice President and CFO, Thomas R. Staab, II, will host a conference call and live webcast on Tuesday, March 3, 2009 at 10:00 a.m. ET.
To access the conference call, U.S. participants may call (877) 648-7970 and international participants may call (706) 902-0415. The conference ID number is 85896375. A live webcast and replay of the call will be available on Inspire's website at [ www.inspirepharm.com ]. A telephone replay of the conference call will be available until March 17, 2009. To access this replay, U.S. participants may call (800) 642-1687 and international participants may call (706) 645-9291. The conference ID number is 85896375.
About Inspire
Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire is currently developing products for dry eye, cystic fibrosis and glaucoma. Inspire employs a U.S. sales force for the promotion of AzaSite® (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis and Elestat® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis. Elestat is a registered trademark owned by Allergan, Inc. AzaSite is a registered trademark owned by InSite Vision Incorporated. For more information, visit [ www.inspirepharm.com ].
